Already Registered? Log In Now Not Registered?
Complete this form to enter the webcast. Already Registered?

(* indicates required field)

Complete this form to enter the webcast.
(* indicates required field)



*Denotes required.


A Carnosine Booster Supporting Mitochondrial Health & GLP-1 Therapies

Thu, Mar 27, 2025 2:00 PM EDT{LOCAL_TZ}
Add to Calendar Add to Calendar

Event Overview:

Mark LeDoux introduces TriBsyn™, a patent-pending wellness innovation, and discusses the role it plays in elevating carnosine, a powerful antioxidant naturally produced in the body. Further, Mark will share recent TriBsyn™ clinical study results and shed light on how TriBsyn™ enhances mitochondrial respiration and detoxification and provides GLP-1 therapy support via improved muscle vitality, muscle working capacity, and cognitive performance.

Key Learning Objectives:
  • Discover the clinical evidence and scientific foundation behind this patent-pending wellness innovation, designed to elevate carnosine levels and support overall health.
  • Understand how this innovation enhances mitochondrial respiration and detoxification, and provides support for GLP-1 therapy through improved muscle vitality, endurance, and cognitive function.
  • Learn how integrating this breakthrough into formulations can optimize product performance and market appeal in the wellness and nutrition space.
Who Should Attend:
  • Product Developers/Formulators
  • Brand Managers
  • R&D Professionals
  • Health & Wellness Industry Leaders
Featured Speaker:

Mark LeDoux
Mark LeDoux
CEO and Chairman of the Board
Natural Alternatives International, Inc.


Mark LeDoux founded Natural Alternatives International (NAI) in 1980. With over 45 years of experience, he is a highly regarded leader and one of the longest-serving active executives in the nutritional supplements industry. As Chairman Emeritus of the prestigious Natural Products Association (NPA), where he has been a member since 1980, Mark represents NAI’s ongoing commitment to industry and government affairs, adherence to a strong code of ethics and continuing support in the legislative, regulatory, and public affairs arenas.

For any technical questions, please contact Jorge de la Bandera: jdelabandera@mjhlifesciences.com